RGC
NASDAQ · Pharmaceuticals
Regencell Bioscience Holding
$29.28
-2.19 (-6.96%)
Performance
1D
—
1W
—
1M
—
3M
+5.65%
6M
+101.38%
1Y
+136.72%
YTD
+42.55%
Open$31.06
Previous Close$31.47
Day High$31.90
Day Low$28.32
52W High$83.60
52W Low$3.93
Volume—
Avg Volume107.0K
Market Cap15.56B
P/E Ratio—
EPS$-0.01
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$27.08
Above
SMA 200
$18.57
Above
RSI (14)
63.8
Neutral
Trend
Golden Cross
Bullish
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.66B | 3.76B | 3.59B |
| Net Income | 706.46M | 788.49M | 815.65M |
| Profit Margin | 19.3% | 21.0% | 22.7% |
| EBITDA | 1.06B | 1.04B | 1.04B |
| Free Cash Flow | 809.03M | 638.27M | 648.55M |
| Rev Growth | +1.6% | +15.1% | +20.8% |
| Debt/Equity | 0.23 | 0.28 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |